Income StatementBalance SheetCash FlowSegments
Xylem logo

Xylem Cash Flow Statement

Operating, investing, and financing cash movements

Xylem generated $1.3B in operating cash flow over the trailing twelve months. After $350.0M in capital expenditures, free cash flow was $966.0M. Free cash flow increased 0.1% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$1.3BNet Cash From Investing (TTM)-$532.0MNet Cash From Financing (TTM)-$1.1BCapital Expenditures (TTM)$350.0MDepreciation And Amortization Cf (TTM)$264.0MNet Change In Cash (TTM)-$251.0M
Latest FilingQ1 2026
Report Date2026-04-28
Market Cap$25.7B
P/E Ratio26.24
ROE9.0%

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired$188.0M$7.0M$0.0$106.0M$50.0M$0.0
Capital expenditures$100.0M$71.0M$98.0M$79.0M$83.0M$90.0M
Payments for asset acquisition at closing—$0.0———$1.0M
Net cash from investing activities-$289.0M-$15.0M-$125.0M-$189.0M-$142.0M-$76.0M
Other investing activities$2.0M$1.0M-$1.0M-$1.0M$1.0M$0.0
Proceeds from sale of businesses$0.0$48.0M$2.0M-$2.0M$1.0M$0.0
Proceeds from sale of property, plant and equipment$1.0M$5.0M$0.0$10.0M$2.0M$1.0M
Purchases of investments$9.0M$1.0M-$1.0M$26.0M$23.0M$0.0

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Change in accounts payable$95.0M-$64.0M$70.0M-$51.0M—-$61.0M
Change in accrued liabilities$4.3M-$17.3M-$17.3M-$17.3M-$17.3M—
Change in inventories—$9.0M$18.0M$3.0M-$53.0M$18.0M
Other working capital changes$145.0M-$161.0M-$64.0M-$35.0M$324.0M-$48.0M
Change in receivables$6.0M$48.0M$55.0M$10.0M—$58.0M
Deferred income taxes-$9.0M-$8.8M-$8.8M-$8.8M-$8.8M—
Depreciation and amortization$67.0M$68.0M$69.0M$64.0M$66.0M$65.0M
Net gains (losses) on investments$38.0M$0.0$0.0$0.0$0.0—
Impairment charges$25.0M$21.0M$26.0M$23.0M$33.0M$31.0M
Net cash from operating activities$575.0M$33.0M$305.0M$360.0M$543.0M$108.0M
Net income$326.0M$169.0M$226.0M$226.0M$329.0M$193.0M
Increase (Decrease) In Long Term Receivables$9.3M$32.0M———$31.0M
Pension contributions$6.3M$6.5M$6.5M$6.5M$6.5M—
Stock-based compensation$13.0M$12.0M$13.0M$12.0M$16.0M$13.0M
Loss on Sale of Subsidiary-$40.0M-$10.0M$0.0-$37.0M—$4.0M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Proceeds from issuance of debt$1.0M$1.0M$3.0M-$3.0M-$1.0M$0.0
Repayments of debt$4.0M$4.0M$24.0M$32.0M$22.0M$4.0M
Dividends paid$87.0M$98.0M$98.0M$97.0M$98.0M$106.0M
Net cash from financing activities-$95.0M-$116.0M-$128.0M-$138.0M-$119.0M-$683.0M
Other financing activities-$5.0M-$8.0M-$11.0M-$8.0M-$7.0M-$10.0M
Proceeds from issuance of common stock$1.0M$6.0M$2.0M$3.0M$9.0M$0.0
Repurchases of common stock$1.0M$13.0M$0.0$1.0M$1.0M$563.0M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$475.0M-$38.0M$207.0M$281.0M$460.0M$18.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$48.0M$25.0M$59.0M-$1.0M$7.0M-$15.0M
Net increase (decrease) in cash$132.0M-$62.0M$111.0M$21.0M$288.0M-$671.0M

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income taxes paid$59.0M$37.0M$138.0M$33.0M$59.0M$28.0M
Interest paid$18.0M$12.0M$20.0M$11.0M$18.0M$11.0M